Cellaria

Cellaria creates high quality, next generation in-vitro disease models that reflect the unique nature of a patient’s biology. All of our models begin with tissue from a patient, capturing clinically relevant details that inform model characterization. For cancer, Cellaria’s cell models exhibit molecular and phenotypic characteristics that are highly concordant to the patient. For RNA-mediated iPS cell line derivation, Cellaria’s cell models enable interrogation of disease-specific mechanisms of action. Cellaria’s innovative products and services help lead the research community to more personalized therapeutics – revolutionizing and accelerating the search for a cure.